Oncology & Cancer

MRI frequently underestimates tumor size in prostate cancer

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

Oncology & Cancer

CRISPR-edited CAR T cells enhance fight against blood cancers

Knocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology enhanced the engineered T cells' ability to eliminate blood cancers, according to new preclinical data from researchers ...

Surgery

Mapping residual esophageal tumors—a glimpse into the future?

It's one of the first questions asked by many newly-diagnosed cancer patients—"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and ...

Oncology & Cancer

Nano-targeting treatment for prostate cancer

Metastatic or castrate-resistant prostate cancer can spread to the bone in certain patients. While several new treatments are available, they can have a difficult time reaching the bone and can result in missing the metastatic ...

page 3 from 9